Stock market news, live
Live stock market headlines that move share prices and indexes, each with an impact score, why it matters and how the stock moved since.
MOST IMPORTANT · LAST 24 HOURS
Saudi Aramco Tower Targeted in Rare Strike on Riyadh Finance Hub
Attack on Saudi capital's financial district threatens Gulf stability and oil-market risk sentiment.
THE WIRE · NEWEST FIRST
- UBS CEO: Midterms Creating Uncertainty for AI Buildout
CEO warning that political gridlock may slow AI data-center spending weighs on AI-linked stocks.
- Advent International Sells 4.4 Million Shares of First Watch Restaurant Group
Block sale by backer lifts share supply, weighing on the small-cap restaurant stock.
- Cullinan Therapeutics Announces Clinical Data for Velinotamig in SLE Patients
Early-stage lupus trial data for a small biotech; promising but early, stock-specific.
- Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat
Positive late-stage trial data for a small biotech; stock-specific, no broad market effect.
- EverCommerce Receives Mixed Analyst Ratings and Price Target Reductions
Multiple analyst downgrades and target cuts signal weakening sentiment for a small-cap software firm.
- PENN Entertainment Targets Texas Gambling Expansion Following Midterm Elections
Casino operator eyes Texas expansion after election shift; speculative, legislative path uncertain.
- Tutor Perini Raises 2026 Earnings Guidance Following Strong Q3 Results
Mid-cap contractor raised earnings guidance sharply; positive for the stock, limited macro relevance.
- Doximity, Inc. Reports Second-Quarter Revenue Beat
Small revenue beat for a mid-cap digital health firm; modest positive but no guidance surprise.
- RadNet Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Mid-cap healthcare imaging firm beat and raised guidance; positive but not sector-moving.
- SB1 Lowers Price Target for Lundin Mining
Analyst price-target cut on a mid-cap miner; limited broader market impact.
- NASA Selects Northrop Grumman for Commercial Lunar Payload Services (CLPS) Framework
A $10B decade-long lunar framework offers upside, but only via competed task orders.
- Alnylam-Licensed Elebsiran Shows Positive Results in Phase 3 ECLIPSE 1 Trial for Hepatitis Delta
Strong Phase 3 hepatitis delta data supports an Alnylam-licensed drug's filing package.
- Digital Realty and Goodman Group Acquire 9.9% Stake in NextDC
Stake exceeds disclosure thresholds but parties ruled out a takeover bid for now.
- NVIDIA Board Initiates Independent Investigation Into Reported Foreign Intelligence Effort Targeting CEO Jensen Huang; Says Board Believes Not Either National Security Or NVIDIA Secrets Were Compromised
Board probe into foreign intelligence targeting its CEO raises governance and risk concerns for a mega-cap.
- Dan Ives Calls Jensen Huang Affair a ‘Black Eye Moment’ for Nvidia, Warns of Stock Overhang
Governance controversy around Nvidia's CEO could weigh on the stock via investigations and uncertainty.
- Asian Markets at Risk of Pressure on Nvidia Probe: Markets Wrap
Nvidia probe uncertainty could weigh on Asian tech stocks at Monday's open.
- Trump Backs Huang as Nvidia CEO After He Admits Affair With Spy
Nvidia leadership question adds reputational risk to a mega-cap key to markets.
- UK Sunday Times Reported Meta Preparing To Launch Muse AI Assistant In UK
Meta launching a UK AI assistant is modest news, signals AI product expansion but limited near-term revenue impact.
- Altimmune Announced Sunday. Phase 2b IMPACT 48-Week Pemvidutide Data In MASH, Showing Significantly Higher Composite Response Rates For Liver Inflammation, Fibrosis Improvement And Disease Remission Vs. Placebo, Supporting Phase 3 Development
Positive mid-stage trial results support Phase 3 plans, a key catalyst for this small biotech stock.
- Nvidia’s Huang Admits Affair With Suspected Chinese Spy, Board Will Investigate
Mega-cap CEO scandal with China-spy angle raises leadership and regulatory risk for Nvidia.
- Hims & Hers Short Interest Climbs to 23% Ahead of Earnings: Can the Stock Break Out?
Heavily shorted mid-cap faces earnings test, with squeeze potential if results surprise.
- KKR, Constellation Energy On Deck Monday As Private Credit, Power Face Test
Earnings from KKR and power names put private credit and electricity demand in focus.
- Anthropic to press ahead with IPO targeting $1.5tn valuation
A $1.5tn AI listing would be a landmark IPO despite tech weakness.
- Trade Desk Stock Is 90% Below Its High. Can Earnings Turn the Tide?
Earnings preview for a beaten-down adtech stock; outcome could swing shares sharply.
- Mettler-Toledo Raises Full-Year 2026 Sales Outlook and Provides 2027 Guidance
Raised sales outlook and 2027 guidance are a positive catalyst for the stock.
That's everything from the last 30 days.
Nothing here yet. New stories appear as they land.